ClinicalTrials.Veeva

Menu

The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale

S

Shantou University Medical College

Status

Completed

Conditions

Non Suicidal Self Injury

Treatments

Other: Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Non-suicidal self-injury (NSSI) is a growing global mental health challenge, distinct from suicidal behavior, with unique risk factors and mechanisms. Existing risk assessment tools do not focus on differentiating NSSI from suicidal self-harm or comprehensively evaluate risk and protective factors specific to NSSI. There is a lack of clinically applicable, validated scales dedicated to assessing NSSI risk, particularly in psychiatric populations. The present study is made to design the Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale, a 39-item scale that evaluates static/dynamic risk factors and protective factors for NSSI in psychiatric patients.

Full description

The initial item pool was created through literature review, semi-structured interviews, and group discussions. Two rounds of the Delphi were employed with twenty experts. We analyzed items using critical ratio, correlation coefficient, factor analysis, and Cronbach's α coefficient. Exploratory factor analysis determined item weights, while reliability analyses evaluated internal consistency, test-retest, inter-observer and split-half methods. In the validity analyses, CVI, construct validity and criterion validity were used. ROC curve established the optimal diagnostic threshold and the risk stratification was performed.

Enrollment

330 patients

Sex

All

Ages

12 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Criteria for inclusion in the sample were individuals , diagnosed with various mental disorders according to the International Classification of Diseases, 10th Revision (ICD-10) diagnostic criteria;
  2. Gender is not limited and aged is 12-30 years old;
  3. The patient's clinical profile is complete and the medical history is detailed;
  4. Informed consent from patients or guardians who signed a consent for.

Exclusion criteria

The patient's clinical profile was incomplete and her medical history was not detailed.

Trial design

330 participants in 1 patient group

Observation Group
Description:
Scales are used to get primary indicator and secondary indicators. The sample size should be set at 5 to 10 times the number of items, with a minimum total sample of 200. Additionally, an extra sample should be calculated to account for a potential 10-20% attrition rate, mitigating the impact of possible data loss. Given that the initial version scale consisted of 55 items, the minimum required sample size is 330.
Treatment:
Other: Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems